(Reuters) – The Indian government has lowered the price at which it buys AstraZeneca’s COVID-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.
“The renegotiated price is significantly lower than 200 rupees ($2.75) per dose,” Health Secretary Rajesh Bhushan told a news conference.
The SII, the world’s biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.
(Reporting by Neha Arora in New Delhi and Sachin Ravikumar in Bengaluru; editing by Jason Neely)
